Diabetic peripheral sensory loss is a major risk factor for diabetic foot ulceration but may remain clinically silent and undetected when screening relies on symptoms alone. In remote primary-care settings, low-cost objective neurological assessment is particularly important. Objective to estimate the prevalence and plantar distribution of monofilament-defined loss of protective sensation (LOPS) and explore its associations with selected demographic, clinical, and neuropathic symptom variables among adults with type 2 diabetes mellitus (T2DM) in Fakfak, Eastern Indonesia. Methods a cross-sectional observational study was conducted among 57 adults with T2DM attending Puskesmas Fakfak Tengah. Six plantar sites on both feet were assessed using a 10-g Semmes-Weinstein monofilament. LOPS was defined as inability to perceive the monofilament at ≥1 site. Descriptive statistics and exploratory Fisher’s exact or chi-square tests were performed, with odds ratios (ORs), 95% confidence intervals (CIs), and two-sided p values. Results mean age was 53.21 ± 11.41 years, and 71.9% were women. Mean random blood glucose was 211.67 ± 84.24 mg/dL, while 56.1% had hypertension. LOPS was identified in 17/57 participants (29.8%; 95% CI 19.5–42.7%). Loss of perception was most frequent at the right first and fifth metatarsal sites (17.5% each) and left fifth metatarsal site (14.0%). Tingling, burning/pain, numbness, and previous diabetic foot wounds were reported by 45.6%, 19.3%, 22.8%, and 8.8%, respectively. Numbness was associated with LOPS (OR 3.97, 95% CI 1.08–14.53; p=0.043). Conclusions nearly one-third of adults with T2DM had objective LOPS on 10-g monofilament screening. These findings support routine objective foot screening in primary care, particularly where symptom reporting may be incomplete. Monofilament testing should complement broader neurological, vascular, and structural foot assessment.
Copyrights © 2026